- Home
- SQNS vs ALGS Comparison
SQNS vs ALGS Comparison
Compare SQNS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- ALGS
- Stock Information
- Founded
- SQNS 2003
- ALGS 2018
- Country
- SQNS France
- ALGS United States
- Employees
- SQNS N/A
- ALGS N/A
- Industry
- SQNS Semiconductors
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- ALGS Health Care
- Exchange
- SQNS Nasdaq
- ALGS Nasdaq
- Market Cap
- SQNS 46.5M
- ALGS 50.4M
- IPO Year
- SQNS 2011
- ALGS 2020
- Fundamental
- Price
- SQNS $4.78
- ALGS $8.50
- Analyst Decision
- SQNS Strong Buy
- ALGS Strong Buy
- Analyst Count
- SQNS 1
- ALGS 1
- Target Price
- SQNS $7.50
- ALGS $70.00
- AVG Volume (30 Days)
- SQNS 10.5M
- ALGS 94.1K
- Earning Date
- SQNS 08-22-2025
- ALGS 08-05-2025
- Dividend Yield
- SQNS N/A
- ALGS N/A
- EPS Growth
- SQNS N/A
- ALGS N/A
- EPS
- SQNS 2.16
- ALGS N/A
- Revenue
- SQNS $38,858,000.00
- ALGS $3,270,000.00
- Revenue This Year
- SQNS N/A
- ALGS N/A
- Revenue Next Year
- SQNS $93.87
- ALGS $51.55
- P/E Ratio
- SQNS $2.50
- ALGS N/A
- Revenue Growth
- SQNS 40.06
- ALGS N/A
- 52 Week Low
- SQNS $0.95
- ALGS $3.76
- 52 Week High
- SQNS $5.83
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- SQNS 90.75
- ALGS 58.69
- Support Level
- SQNS $1.34
- ALGS $8.13
- Resistance Level
- SQNS $5.83
- ALGS $9.10
- Average True Range (ATR)
- SQNS 0.55
- ALGS 0.67
- MACD
- SQNS 0.46
- ALGS 0.06
- Stochastic Oscillator
- SQNS 92.56
- ALGS 73.64
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.